Zobrazeno 1 - 10
of 287
pro vyhledávání: '"Luis M, Vilá"'
Autor:
Ileana Rivera-Burgos, Luis M. Vilá
Publikováno v:
Case Reports in Rheumatology, Vol 2024 (2024)
Tumor necrosis factor alpha inhibitors (TNFi) are biological drugs used worldwide to treat various autoimmune disorders. Paradoxically, TNF-α antagonists can also induce autoimmune diseases being systemic vasculitis, systemic lupus erythematosus, an
Externí odkaz:
https://doaj.org/article/51ebbc16b72f46c0b66ff0cf24fb551c
Autor:
Rafael A. Ríos-Rivera, Luis M. Vilá
Publikováno v:
Case Reports in Rheumatology, Vol 2023 (2023)
Relapsing polychondritis (RPC) is an uncommon autoimmune systemic disease characterized by recurrent inflammation of the cartilage tissue. It can occur alone or in association with other autoimmune diseases, vasculitis, or hematologic disorders. Howe
Externí odkaz:
https://doaj.org/article/8bf2522f9d194a4b826eb238a329883a
Autor:
Luis M. Vilá, Mariely Nieves-Plaza, Xariana Vales Torres, Benjamín Nieves, A. Valance Washington
Publikováno v:
European Journal of Rheumatology, Vol 10, Iss 2, Pp 88-89 (2023)
Externí odkaz:
https://doaj.org/article/a08e6cc99b634cb1800b7c9336cd5295
Autor:
Ariana González-Meléndez, Abiel Roche-Lima, Claudia P. Amaya Ardila, Luis M. Vilá, Elizabeth Brown
Publikováno v:
Journal of Clinical and Translational Science, Vol 7, Pp 92-92 (2023)
OBJECTIVES/GOALS: Cardiovascular disease (CVD) is the most common cause of death in systemic lupus erythematosus (SLE). Genome-wide association studies have identified single nucleotide polymorphisms linked with CVD risk, but the association with SLE
Externí odkaz:
https://doaj.org/article/54afd5a73f824ae18e60369aa0c5583e
Autor:
Patricia Jordán-González, Ricardo Gago-Piñero, Noemí Varela-Rosario, Naydi Pérez-Ríos, Luis M. Vilá
Publikováno v:
European Journal of Rheumatology, Vol 7, Iss 3, Pp 112-117 (2020)
Externí odkaz:
https://doaj.org/article/fbcb52ee67b849c981382a3b9a61b4e2
Autor:
Suheiry Márquez, Luis M. Vilá
Publikováno v:
Case Reports in Rheumatology, Vol 2022 (2022)
Transverse myelitis (TM) is a rare complication seen in 1–2% of patients with systemic lupus erythematosus (SLE). Viral infections may cause TM in these patients by causing a dysregulation of their immune system. We report a 30-year-old woman with
Externí odkaz:
https://doaj.org/article/72e9add248754e5aa3de5844e5d6fc4e
Autor:
Laisha Báez-Negrón, Luis M. Vilá
Publikováno v:
Case Reports in Rheumatology, Vol 2022 (2022)
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease resulting from the interaction of genetic and environmental factors. In addition, some antiviral vaccines have been associated with the onset of SLE. Few cases of SLE occurring af
Externí odkaz:
https://doaj.org/article/470aaa4a5c88449a9f9261f60e8e10b5
Publikováno v:
BMJ case reports. 15(3)
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by symmetric inflammatory polyarthritis. However, RA limited to a single joint is extremely rare. Here, we report a middle-aged woman who presented with insidious right elbow art
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6411ffdfa0ed6604459ed7ce5f74296
https://pubmed.ncbi.nlm.nih.gov/35256364
https://pubmed.ncbi.nlm.nih.gov/35256364
Autor:
Meenakshi Jolly, Bhavika Sethi, Courtney O'Brien, Winston Sequeira, Joel A. Block, Sergio Toloza, Ana Bertoli, Ivana Blazevic, Luis M. Vilá, Ioana Moldovan, Karina D. Torralba, Elvira Cicognani, Davide Mazzoni, Sarfaraz Hasni, Berna Goker, Seminur Haznedaroglu, Josiane Bourre‐Tessier, Sandra V. Navarra, Chi Chiu Mok, Ann Clarke, Michael Weisman, Daniel Wallace
Publikováno v:
ACR Open Rheumatology, Vol 1, Iss 10, Pp 649-656 (2019)
Objective Quality of life (QOL) and quality of care (QOC) in systemic lupus erythematosus (SLE) remains poor. Satisfaction with care (SC), a QOC surrogate, correlates with health behaviors and outcomes. This study aimed to determine correlates of SC
Externí odkaz:
https://doaj.org/article/31c0257e19704594b25f6c6517621ff8
Autor:
Ariana González-Meléndez, Laisha Báez-Negrón, Rafael Ríos-Rivera, Alexandra S Franco-O’Connell, Mariely Nieves-Plaza, Luis M Vilá
Publikováno v:
Lupus. 32:571-579
Objective To determine if SARS-CoV-2 mRNA vaccination has an impact on the clinical course of systemic lupus erythematosus (SLE). Methods Puerto Ricans with SLE who received mRNA COVID-19 vaccines were studied. Demographic parameters, clinical manife
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::960c8854b2349569b14cdd2fb198a730
https://doi.org/10.1177/09612033231151898
https://doi.org/10.1177/09612033231151898